TrialProgress in neuro-psychopharmacology & biological psychiatry2015

Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder.

Richard De La Garza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.